Hazel M. Aker serves as Executive at CANCERVAX CORP, where they oversee executive responsibilities. Since joining the company, Hazel M. Aker has executed 17 insider transactions totaling $739.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 21, 2020 involved purchasing 41,972 shares valued at $99.9K.
Hazel M. Aker currently holds 46,987 shares of CANCERVAX CORP (CNVX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hazel M. Aker has been a net seller of CNVX stock. They have purchased $99.9K and sold $639.7K worth of shares.
Hazel M. Aker's most recent insider trade was on Jul 21, 2020, when they purchased 41,972 shares at $2.38 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 7, 2019 | ONCT | $0 | Award | 5,015 | $N/A | Discretionary |
| Mar 19, 2014 | CADX | $52.4K | Tender | 3,745 | $14.00 | Discretionary |
| Dec 16, 2013 | CADX | $114.0K | Sale | 13,014 | $8.76 | Discretionary |
| Dec 16, 2013 | CADX | $45.7K | Option Exercise | 13,014 | $3.51 | Discretionary |
| Nov 15, 2013 | CADX | $203.3K | Sale | 26,028 | $7.81 | Discretionary |
| Nov 15, 2013 | CADX | $182.2K | Sale | 26,028 | $7.00 | Discretionary |
| Nov 15, 2013 | CADX | $182.7K | Option Exercise | 52,056 | $3.51 | Discretionary |
| Jul 22, 2013 | CADX | $50.8K | Sale | 6,507 | $7.81 | Discretionary |
| Jul 22, 2013 | CADX | $22.8K | Option Exercise | 6,507 | $3.51 | Discretionary |
| Jul 15, 2013 | CADX | $47.8K | Sale | 6,508 | $7.34 | Discretionary |
| Jul 15, 2013 | CADX | $22.8K | Option Exercise | 6,508 | $3.51 | Discretionary |
| Nov 21, 2011 | CADX | $41.6K | Sale | 10,000 | $4.16 | Discretionary |
| Nov 2, 2011 | CADX | $0 | Option Exercise | 10,000 | $N/A | Discretionary |
| Feb 20, 2008 | CADX | $20.0K | Award | 3,745 | $5.34 | Discretionary |
| Mar 20, 2006 | CNVX | $0 | Award | 13,579 | $N/A | Discretionary |